Ophthalmology
-
Comparative Study
Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
Anti-vascular endothelial growth factor therapies have revolutionized the treatment of clinically significant diabetic macular edema (CSDME); yet these agents are expensive, and whether they are cost-effective is unclear. The purpose of this study is to determine the most cost-effective treatment option for patients with newly diagnosed CSDME: focal laser photocoagulation alone (L), focal laser plus intravitreal ranibizumab (L+R), focal laser plus intravitreal bevacizumab (L+B), or focal laser plus intravitreal triamcinolone (L+T) injections. ⋯ The author(s) have no proprietary or commercial interest in any materials discussed in this article.
-
To estimate the economic burden of vision loss and eye disorders in the United States population younger than 40 years in 2012. ⋯ The author(s) have no proprietary or commercial interest in any materials discussed in this article.
-
To report the occurrence of actinic granuloma of the conjunctiva in young women. ⋯ The author(s) have no proprietary or commercial interest in any materials discussed in this article.